U.S. Real Estate Stock News

Wondering if Ellington Financial at US$13.33 is offering genuine value or just feels cheap on the surface? This article walks through the key signals you can use to judge it. The stock has been a mixed ride recently, with the share price down 2.1% over the past week, up 2.9% over the last month, and showing a 13.4% return over the past year, alongside longer term returns of 54.1% over 3 years and 30.1% over 5 years. Recent coverage has focused on Ellington Financial's position within the...

Antero Resources (NYSE:AR) recently saw a material benefit from a sharp move in natural gas prices linked to Middle East supply disruptions. Growing U.S. demand for natural gas from AI data centers also supported the company’s position. Management highlighted strong free cash flow and a delevered balance sheet alongside these market shifts. Antero Resources focuses on natural gas and liquids, so the recent price swing tied to Middle East supply concerns feeds directly into its core...

We wouldn't blame Guardant Health, Inc. ( NASDAQ:GH ) shareholders if they were a little worried about the fact that...

We wouldn't blame Privia Health Group, Inc. ( NASDAQ:PRVA ) shareholders if they were a little worried about the fact...

Gemini Space Station (GEMI) opened Q1 2026 earnings season with Q4 2025 revenue of US$60.3 million, a basic EPS loss of US$1.22 and net income loss of US$140.8 million. This has set a clear focus on how quickly the business can tighten its cost base around a growing top line. The company has seen quarterly revenue move from US$24.5 million in Q3 2024 to US$34.3 million in Q1 2025 and then to US$60.3 million in Q4 2025. Over the same period, quarterly basic EPS losses shifted from US$18.33 to...

We'd be surprised if Greenlight Capital Re, Ltd. ( NASDAQ:GLRE ) shareholders haven't noticed that the General Counsel...

Cognex (NasdaqGS:CGNX) has announced the general availability of OneVision, an AI vision development platform for factory automation. OneVision is designed to centralize the creation, deployment, and management of AI-powered inspections across manufacturing operations. The platform targets manufacturers looking to scale AI vision from single production lines to multi site or global operations. Cognex enters this launch with the stock at $64.26, a move up 74.0% year to date and 104.6% over...

Investors may be wondering if CBRE Group at around US$129.95 is starting to look attractive again, or if the stock is still pricing in too much optimism. The share price has fallen 11.2% over the past week, 14.2% over the past month and 18.9% year to date, even though the 3 year and 5 year returns sit at 68.2% and 49.1% respectively. This may have changed how the market is thinking about its risk and potential. Recent coverage has focused on how real estate services companies like CBRE Group...

Dole plc (NYSE:DOLE) is set to be added to the MSCI ACWI Investable Market Index, MSCI ACWI Small Cap Index, and MSCI USA Small Cap Index. The index changes are scheduled to take effect on May 29, 2026. The inclusion may influence Dole's visibility with index-tracking funds and passive investors. Dole, trading at $14.1, is coming into these index additions with a mixed return profile. The stock is down 5.2% over the past week, down 7.1% over the past 30 days, and down 3.6% year to date,...

FLEX LNG plans to delist from the Oslo Stock Exchange and move to exclusive trading on the NYSE under ticker NYSE:FLNG. The company has raised its full year 2026 financial guidance and expanded its long term charter backlog. New and extended charter contracts now secure 91% of available vessel days for 2026. FLEX LNG, which last closed at $32.13, has shown strong share price performance, up 30.2% year to date and 45.7% over the past year. Over 5 years, the stock is up 280.2%, reflecting how...

We'd be surprised if Boise Cascade Company ( NYSE:BCC ) shareholders haven't noticed that the Senior VP, Jill Twedt...

We wouldn't blame MaxLinear, Inc. ( NASDAQ:MXL ) shareholders if they were a little worried about the fact that Connie...

Shift4 Payments, Inc. ( NYSE:FOUR ) shareholders (or potential shareholders) will be happy to see that insider Jared...

Investors may wish to note that the Independent Director of Citizens Community Bancorp, Inc. , James Moll, recently...

Anyone interested in Collegium Pharmaceutical, Inc. ( NASDAQ:COLL ) should probably be aware that the Independent...

We wouldn't blame Ormat Technologies, Inc. ( NYSE:ORA ) shareholders if they were a little worried about the fact that...

We note that the CPI Card Group Inc. ( NASDAQ:PMTS ) Chief Accounting Officer & Controller, Donna Carmignani, recently...

Anyone interested in Axcelis Technologies, Inc. ( NASDAQ:ACLS ) should probably be aware that the VP of Corporate...

Eastman Kodak (KODK) is in focus after Hubble Connected unveiled plans for a new line of Kodak licensed smart family products, set to debut at the ABC Kids Expo in Las Vegas. See our latest analysis for Eastman Kodak. The licensing news lands after a mixed stretch in the stock, with the share price down 26.37% over the past 30 days but up 26.34% over 90 days and a 49.31% one year total shareholder return, suggesting momentum has been choppy rather than moving in a single direction. If this...

Investors who take an interest in Aware, Inc. ( NASDAQ:AWRE ) should definitely note that the Independent Director...

We wouldn't blame UFP Technologies, Inc. ( NASDAQ:UFPT ) shareholders if they were a little worried about the fact that...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Investors who take an interest in Strattec Security Corporation ( NASDAQ:STRT ) should definitely note that the Senior...

Mirum Pharmaceuticals reported positive topline VISTAS Phase 2b results for volixibat in primary sclerosing cholangitis related cholestatic pruritus. The trial showed a robust, clinically meaningful improvement in itch symptoms for PSC patients, who currently have no approved treatment options. Following the data, Mirum has a pre NDA meeting scheduled and plans to file for regulatory approval for volixibat. For investors tracking Mirum Pharmaceuticals, ticker NasdaqGM:MIRM, this update sits...